Before you start the trialsee the eligibility rates
Check your eligibility criteria against real-world data first.
Which of these eligibility criteria has the lowest eligibility rate?
trial-protocol.pdf
Backed by
Eligibility, checked upfront
Reduce guesswork upfront and optimize your clinical process on real-world data (RWD).
See eligibility rates by criterion
See eligibility rates down to biomarkers and lab values, criterion by criterion.
Creatinine ≤ 1.538%
≤ 2 prior therapies59%
ECOG 0–177%
Age 19–7591%
Eligibility rate by criterion (illustrative)
Find the criteria that work
Adjust and compare criteria to find the highest eligibility rate. One small criterion can make a large difference.
18%As written37%Broadened
Prior therapies 2 → 3 (illustrative)
Frequently asked questions
Is IRB review not required?
The exploratory stage runs without review. Results are de-identified and counts for very small groups are not shown, so it does not constitute research using identifiable information. Once you settle on a hypothesis and move to the study itself, IRB approval is required.
Is patient personal information visible?
No. Every identifier is removed before analysis, counts for very small groups are not shown, and only the minimum clinically meaningful information is used.
Can results be used for publications or regulatory submissions as is?
Not as is. Once you have IRB approval, you can review the de-identified source records behind a finding and use them either as a citation in your paper or as supporting material in a regulatory filing. We help you prepare for that review.
Where are patient records stored?
Everything is stored encrypted, and records stay in the country the patient consented in.
